Saturation ligand binding analyses for [3H]nemonapride, [3H]raclopride, and [3H]spiperone binding to D2 dopamine receptors expressed in Sf9 cells Saturation binding studies were performed as described under Materials and Methods section with [3H]nemonapride, [3H]raclopride, and [3H]spiperone using different preparations of Sf9 cell membranes expressing the D2 dopamine receptor, under control conditions or with 100 mM sodium ions. Experiments with preparation 3 included 0.1% bovine serum albumin as described under Materials and Methods. All saturation analyses fitted best to one-binding site models from which Bmax (pmol/mg) and pKd values were determined and are expressed as mean ± S.E.M. from three or more experiments.
Radioligand | Bmax | pKd | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Preparation 1 | Preparation 2 | Preparation 3 | Preparation 1 | Preparation 2 | Preparation 3 | |||||||
Control | Na+ | Control | Na+ | Control | Na+ | Control | Na+ | Control | Na+ | Control | Na+ | |
[3H]Nemonapride | 0.92 ± 0.04 | 1.53 ± 0.04* | 4.13 ± 0.17 | 5.28 ± 0.26* | 3.37 ± 0.26 | 6.13 ± 0.28* | 9.81 ± 0.20 | 10.76 ± 0.11* | 10.02 ± 0.03 | 10.34 ± 0.12* | 9.62 ± 0.07 | 10.51 ± 0.06* |
[3H]Raclopride | N.D. | 0.32 ± 0.18 | N.D. | 2.32 ± 0.29 | N.D. | 2.20 ± 0.60 | N.D. | 8.67 ± 0.15 | N.D. | 8.69 ± 0.05 | N.D. | 8.83 ± 0.11 |
[3H]Spiperone | 0.98 ± 0.06 | 0.99 ± 0.06 | 4.03 ± 0.75 | 4.23 ± 0.23 | 2.64 ± 0.19 | 3.54 ± 0.15* | 10.47 ± 0.06 | 10.35 ± 0.06 | 10.01 ± 0.09 | 9.77 ± 0.13 | 9.99 ± 0.07 | 9.81 ± 0.03* |
N.D., not determined because no saturable high-affinity binding could be detected.
↵* Different from control (P < 0.05)